Palonosetron-induced migraine-type headache.
Amit
A
Jain
D000328:Adult; D000758:Anesthesia / Q000009:adverse effects / Q000379:methods; D000932:Antiemetics / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007546:Isoquinolines / Q000009:adverse effects* / Q000627:therapeutic use; D010535:Laparoscopy / Q000379:methods; D008881:Migraine Disorders / Q000139:chemically induced* / Q000503:physiopathology; D000077924:Palonosetron; D020250:Postoperative Nausea and Vomiting / Q000517:prevention & control; D011812:Quinuclidines / Q000009:adverse effects* / Q000627:therapeutic use; D012702:Serotonin Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D012720:Severity of Illness Index
D000932:Antiemetics; D007546:Isoquinolines; D011812:Quinuclidines; D012702:Serotonin Antagonists; D000077924:Palonosetron